US Patent Issued to JUVENTAS CELL THERAPY on Oct. 14 for "Plasmid combination and application thereof in preparing modified immune cells" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,779, issued on Oct. 14, was assigned to JUVENTAS CELL THERAPY LTD. (Tianjin, China).

"Plasmid combination and application thereof in preparing modified immune cells" was invented by Yun Liu (Tianjin, China), Lin Shi (Tianjin, China), Lulu Lv (Tianjin, China), Pan Xie (Tianjin, China), Mengmeng Cao (Tianjin, China), Wang Yang (Tianjin, China), Jiaxing Yang (Tianjin, China), Fei Wang (Tianjin, China) and Rui Wang (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present disclosure is a method for using a four-plasmid system to prepare modified immune effector cells. The method comprises: forming a lentivirus by using four ...